Skip to Main Content

Advertisement

Skip Nav Destination

CASTOR Trial: Daratumumab Combination Doubles Response Rates in Myeloma Patients

December 30, 2021


Antonio Palumbo, MD, discusses the “unprecedented” results of the CASTOR Trial, a plenary, late-breaking abstract at ASCO 2016.

Advertisement

  CURRENT ISSUE
  Mid-January 2022

Advertisement

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement

X